Literature DB >> 29906313

The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.

Younghoon Kim1,2, Xianyu Wen1,2, Jeong M Bae1,3, Jung H Kim1,3, Nam-Yun Cho1, Gyeong H Kang1,2.   

Abstract

AIMS: The role of tumour-associated macrophages (TAMs) in colorectal cancer (CRC) remains elusive. In this study, we aimed to examine the correlation between TAMs, clinicopathological features, tumour-infiltrating lymphocytes (TILs) and prognosis in CRC by the use of image analysis. METHODS AND
RESULTS: Immunohistochemical staining for CD68 and CD163 was performed as pan-macrophage and M2-macrophage markers, respectively. Each marker was analysed separately for intra-epithelial and stromal area densities. All four macrophage densities showed a significant correlation with one another (P = 0.001). Intra-epithelial CD68+ macrophage densities showed a correlation with pTNM stage (P = 0.008), microsatellite instability (MSI) (P < 0.001), CpG island methylator phenotype (CIMP) (P < 0.001) and TIL densities (P < 0.001). Intra-epithelial CD163+ macrophage densities were associated with perineural invasion, MSI, CIMP and TIL densities (P < 0.001). Stromal CD68+ and CD163+ macrophage densities had a significant relationship with intra-epithelial and stromal CD3+ (P = 0.001 and P < 0.001, respectively) and CD8+ (P < 0.001) T cells. High intra-epithelial CD68+ macrophage density was associated with worse overall survival (HR = 1.386, 95% CI = 1.043-1.843, P = 0.025) and progression-free survival (HR = 1.522, 95% CI = 1.146-2.020, P = 0.004). Intra-epithelial CD68+ macrophage density was also an independent prognostic factor of the progression-free survival (HR = 1.447, 95% CI = 1.076-1.947, P = 0.015) of CRC patients regardless of pTNM stage, lymphatic, venous, and perineural invasions and TIL densities.
CONCLUSION: Our results indicate that the density of intratumoural macrophages is a useful prognostic indicator for further stratifying T cell populations in CRC.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  colorectal carcinoma; computer-assisted image analysis; macrophages; prognosis; tumour-infiltrating lymphocytes

Mesh:

Year:  2018        PMID: 29906313     DOI: 10.1111/his.13674

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  17 in total

1.  Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.

Authors:  Zheng Wang; Jingru Song; Nisma Lena Bahaji Azami; Mingyu Sun
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

Review 2.  Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer.

Authors:  Yamei Zhao; Xiaoxu Ge; Xiaoming Xu; Shaojun Yu; Jian Wang; Lifeng Sun
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-24       Impact factor: 4.553

3.  Prognostic value and predictive biomarkers of phenotypes of tumour-associated macrophages in colorectal cancer.

Authors:  Yu Kou; Zhuoqun Li; Qidi Sun; Shengnan Yang; Yunshuai Wang; Chen Hu; Huijie Gu; Huangjian Wang; Hairong Xu; Yan Li; Baowei Han
Journal:  Scand J Immunol       Date:  2022-01-10       Impact factor: 3.889

4.  Elevated CD163+/CD68+ Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer.

Authors:  Chaogang Yang; Chen Wei; Shuyi Wang; Dongdong Shi; Chunxiao Zhang; Xiaobin Lin; Rongzhang Dou; Bin Xiong
Journal:  Int J Biol Sci       Date:  2019-03-10       Impact factor: 6.580

5.  Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer.

Authors:  Bei Li; Qian Yang; Zhiyu Li; Zhiliang Xu; Si Sun; Qi Wu; Shengrong Sun
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

6.  CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.

Authors:  Daniëlle Krijgsman; Natasja L De Vries; Morten N Andersen; Anni Skovbo; Rob A E M Tollenaar; Holger J Møller; Marianne Hokland; Peter J K Kuppen
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

7.  IRF4 overexpression promotes the transdifferentiation of tregs into macrophage-like cells to inhibit the development of colon cancer.

Authors:  Jiwei Wang; Song Li; Honglang Li; Xiaoshuang Zhou; Huabin Wen; Bin Lai
Journal:  Cancer Cell Int       Date:  2021-01-19       Impact factor: 5.722

8.  The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment.

Authors:  Juha P Väyrynen; Koichiro Haruki; Mai Chan Lau; Sara A Väyrynen; Jeffrey A Meyerhardt; Marios Giannakis; Shuji Ogino; Jonathan A Nowak; Rong Zhong; Andressa Dias Costa; Jennifer Borowsky; Melissa Zhao; Kenji Fujiyoshi; Kota Arima; Tyler S Twombly; Junko Kishikawa; Simeng Gu; Saina Aminmozaffari; Shanshan Shi; Yoshifumi Baba; Naohiko Akimoto; Tomotaka Ugai; Annacarolina Da Silva; Jennifer L Guerriero; Mingyang Song; Kana Wu; Andrew T Chan; Reiko Nishihara; Charles S Fuchs
Journal:  Cancer Immunol Res       Date:  2020-10-06       Impact factor: 12.020

9.  Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn's Disease: A Comparative Pilot Study.

Authors:  J Torle; P D Dabir; U Korsgaard; J Christiansen; N Qvist; A El-Hussuna
Journal:  Surg Res Pract       Date:  2020-02-21

Review 10.  The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.

Authors:  Silvia Mola; Chiara Pandolfo; Antonio Sica; Chiara Porta
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.